The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Wayne M. Clark

Department of Neurology CR131

Oregon Health Sciences University

Oregon Stroke Center

Portland

USA

[email]@ohsu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Neurology CR131, Oregon Health Sciences University, Oregon Stroke Center, Portland, USA. 2009
  • Oregon Stroke Center, Oregon Health Sciences University, Portland, Oregon 97201. 1998 - 2001
  • Oregon Stroke Center, Dept. of Neurology UHS44, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, USA. 2001
  • Oregon Stroke Center, Portland 97201, USA. 1999 - 2000

References

  1. Efficacy of citicoline as an acute stroke treatment. Clark, W.M. Expert. Opin. Pharmacother (2009) [Pubmed]
  2. Efficacy of antioxidant therapies in transient focal ischemia in mice. Clark, W.M., Rinker, L.G., Lessov, N.S., Lowery, S.L., Cipolla, M.J. Stroke (2001) [Pubmed]
  3. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Clark, W.M., Wechsler, L.R., Sabounjian, L.A., Schwiderski, U.E. Neurology (2001) [Pubmed]
  4. Potential of anticytokine therapies in central nervous system ischaemia. Clark, W.M., Lutsep, H.L. Expert. Opin. Biol. Ther (2001) [Pubmed]
  5. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Clark, W.M., Albers, G.W., Madden, K.P., Hamilton, S. Stroke (2000) [Pubmed]
  6. Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators. Clark, W.M., Raps, E.C., Tong, D.C., Kelly, R.E. Stroke (2000) [Pubmed]
  7. Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agents. Clark, W.M., Lutsep, H.L. Neuroimaging Clin. N. Am. (1999) [Pubmed]
  8. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Clark, W.M., Williams, B.J., Selzer, K.A., Zweifler, R.M., Sabounjian, L.A., Gammans, R.E. Stroke (1999) [Pubmed]
  9. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark, W.M., Wissman, S., Albers, G.W., Jhamandas, J.H., Madden, K.P., Hamilton, S. JAMA (1999) [Pubmed]
  10. Citicoline treatment for experimental intracerebral hemorrhage in mice. Clark, W., Gunion-Rinker, L., Lessov, N., Hazel, K. Stroke (1998) [Pubmed]
 
WikiGenes - Universities